Company Overview
About Kernal Biologics
Kernal Biologics is a clinical-stage biotech developing AI-designed mRNA therapeutics for cancer and autoimmune diseases — using machine learning to engineer cell-type-specific mRNA sequences that direct therapeutic payloads (including CAR-T gene programs) to the right cells in vivo, enabling off-the-shelf CAR-T cancer therapy without the individualized cell extraction and ex vivo manufacturing process that makes current CAR-T treatments cost $400,000+ and require weeks of production time. The Y Combinator-backed company has raised $35.8 million including a $25 million Series A led by Hummingbird Ventures with participation from Amgen Ventures.
Business Model & Competitive Advantage
Kernal's platform analyzes transcriptome data to identify cell-type-specific RNA regulatory elements — promoters, UTRs, and expression signals that direct which cell types will take up and express a given mRNA. By engineering these regulatory elements using ML-guided design, Kernal can create mRNA constructs that preferentially express in specific cell populations (T cells, B cells, macrophages) after systemic delivery, enabling CAR-T programs to work without ex vivo cell collection. The lead program KR-335 is advancing toward IND filing for immuno-oncology indication.
Competitive Landscape 2025–2026
In 2025, Kernal competes in the mRNA therapeutics and cell therapy market with Moderna, BioNTech, and In Vivo Therapeutics for next-generation mRNA platforms, and with Beam Therapeutics, Prime Medicine, and other ex vivo CAR-T developers for the oncology and autoimmune indication space. The promise of in vivo CAR-T — delivering a gene therapy injection that programs the patient's own immune cells to fight cancer — represents a potential transformation of a $20B+ CAR-T market by eliminating the manufacturing complexity. Amgen Ventures' participation signals pharma interest in next-generation cell therapy platforms. The 2025 strategy focuses on advancing KR-335 toward clinical trials, building the mRNA design platform evidence base, and exploring partnership opportunities with larger biopharma companies for CAR-T and autoimmune indications.
Open Positions
Reddit Discussions
Key Differentiators
Emerging Innovator
Kernal Biologics is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Not So Random Others
AbbVie
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Sp
Yoneda Labs
Yoneda Labs is a San Francisco-based AI company applying foundation models to automate chemical reaction optimization for drug discovery and pharmaceutical process development — providing chemists wit
YouShift
YouShift is a United States-based AI healthcare workforce management platform — building the operating system for healthcare staffing starting with AI-powered scheduling agents that replace the comple
Decoda Health
Decoda Health is a San Francisco-based AI healthcare administration platform — backed by Y Combinator (S23) with $4.5 million raised from YC, Amino Capital, Bossa Nova Ventures, Cadenza Ventures, Grap
Abacum
Abacum is an FP&A (Financial Planning and Analysis) automation platform helping finance teams at growth-stage companies build automated financial models, track KPIs in real time, and collaborate on bu
Uncommon Therapeutics
Uncommon Therapeutics is a biotech company founded by Noah Auerhahn — directly inspired by his daughter's diagnosis with Rett Syndrome, a severe genetic neurological disease affecting approximately 1
Compare Kernal Biologics with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Kernal Biologics? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Kernal Biologics Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Kernal Biologics vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →